Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 283

1.

Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.

Frantz C, Huscher D, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Siegert E, Lazzaroni MG, Carreira PE, Vettori S, Zanatta E, Ullman S, Czirjàk L, Kowal-Bielecka O, Distler O, Matucci-Cerinic M, Allanore Y; EUSTAR co-authors.

Autoimmun Rev. 2019 Dec 12:102452. doi: 10.1016/j.autrev.2019.102452. [Epub ahead of print] Review.

PMID:
31838157
2.

[Systemic sclerosis].

Schinke S, Riemekasten G.

Internist (Berl). 2019 Dec;60(12):1251-1269. doi: 10.1007/s00108-019-00699-7. Review. German.

PMID:
31754753
3.

IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus Nephritis.

Rose A, von Spee-Mayer C, Kloke L, Wu K, Kühl A, Enghard P, Burmester GR, Riemekasten G, Humrich JY.

Cells. 2019 Oct 11;8(10). pii: E1234. doi: 10.3390/cells8101234.

4.

Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome.

Ernst D, Westerbergh J, Sogkas G, Jablonka A, Ahrenstorf G, Schmidt RE, Heidecke H, Wallentin L, Riemekasten G, Witte T.

Sci Rep. 2019 Oct 10;9(1):14552. doi: 10.1038/s41598-019-51125-9.

5.

Prevalence, Risk Factors and Assessment of Depressive Symptoms in Patients With Systemic Sclerosis.

March C, Huscher D, Preis E, Makowka A, Hoeppner J, Buttgereit F, Riemekasten G, Norman K, Siegert E.

Arch Rheumatol. 2019 Jan 28;34(3):253-261. doi: 10.5606/ArchRheumatol.2019.7111. eCollection 2019 Sep.

6.

Does angiotensin and endothelin receptor blockade have an impact on lung function? An analysis from the EUSTAR database.

Radic M, Becker MO, Distler O, Huscher D, Siegert E, Riemekasten G; EUSTAR group.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):154-155. Epub 2019 Sep 26. No abstract available.

7.

Evaluation of choroidal substructure perfusion in patients affected by systemic sclerosis: an optical coherence tomography angiography study.

Ranjbar M, Rothe M, Klapa S, Lange T, Prasuhn M, Grisanti S, Riemekasten G, Humrich JY.

Scand J Rheumatol. 2019 Sep 17:1-5. doi: 10.1080/03009742.2019.1641616. [Epub ahead of print]

PMID:
31526060
8.

Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: results of the DeSScipher inception cohort study.

Valentini G, Huscher D, Riccardi A, Fasano S, Irace R, Messiniti V, Matucci-Cerinic M, Guiducci S, Distler O, Maurer B, Avouac J, Tarner IH, Frerix M, Riemekasten G, Siegert E, Czirják L, Lóránd V, Denton CP, Nihtyanova S, Walker UA, Jaeger VK, Del Galdo F, Abignano G, Ananieva LP, Gherghe AM, Mihai C, Henes JC, Schmeiser T, Vacca A, Moiseev S, Foeldvari I, Gabrielli A, Krummel-Lorenz B, Rednic S, Allanore Y, Müeller-Ladner U.

Ann Rheum Dis. 2019 Nov;78(11):1576-1582. doi: 10.1136/annrheumdis-2019-215486. Epub 2019 Aug 7.

PMID:
31391176
9.

Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice.

Klocke J, Ulu A, Wu K, Rudolph B, Dragun D, Gollasch M, Schunck WH, Hammock BD, Riemekasten G, Enghard P.

Sci Rep. 2019 Jun 20;9(1):8993. doi: 10.1038/s41598-019-45299-5.

10.

Decreased endothelin receptor A autoantibody levels are associated with early ischaemic events in patients with giant-cell arteritis.

Klapa S, Müller A, Koch A, Heidecke H, Kähler W, Junker J, Schinke S, Riemekasten G, Lamprecht P.

Ann Rheum Dis. 2019 Oct;78(10):1443-1444. doi: 10.1136/annrheumdis-2019-215341. Epub 2019 Jun 11. No abstract available.

PMID:
31186255
11.

Large variability of frequency and type of physical therapy in patients of the German Network for Systemic Sclerosis.

Belz D, Moinzadeh P, Riemekasten G, Henes J, Müller-Ladner U, Blank N, Koetter I, Siegert E, Pfeiffer C, Schmalzing M, Zeidler G, Schmeiser T, Worm M, Guenther C, Susok L, Kreuter A, Sunderkoetter C, Juche A, Aberer E, Gaebelein-Wissing N, Ramming A, Kuhr K, Hunzelmann N.

Arthritis Care Res (Hoboken). 2019 May 31. doi: 10.1002/acr.23998. [Epub ahead of print]

PMID:
31150152
12.

Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.

Blagojevic J, Abignano G, Avouac J, Cometi L, Frerix M, Bellando-Randone S, Guiducci S, Bruni C, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Czirják L, Denton CP, Distler O, Allanore Y, Müller-Ladner U, Moggi-Pignone A, Matucci-Cerinic M, Del Galdo F; EUSTAR co-workers.

Clin Rheumatol. 2020 Jan;39(1):27-36. doi: 10.1007/s10067-019-04564-8. Epub 2019 May 20.

PMID:
31111363
13.

Association between baseline clinical and imaging findings and the development of digital ulcers in patients with systemic sclerosis.

Friedrich S, Lüders S, Glimm AM, Werner SG, Schmittat G, Burmester GR, Backhaus M, Riemekasten G, Ohrndorf S.

Arthritis Res Ther. 2019 Apr 15;21(1):96. doi: 10.1186/s13075-019-1875-1.

14.

Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.

Sobanski V, Giovannelli J, Allanore Y, Riemekasten G, Airò P, Vettori S, Cozzi F, Distler O, Matucci-Cerinic M, Denton C, Launay D, Hachulla E; EUSTAR Collaborators.

Arthritis Rheumatol. 2019 Sep;71(9):1553-1570. doi: 10.1002/art.40906. Epub 2019 Aug 12.

15.

Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.

Moinzadeh P, Kuhr K, Siegert E, Blank N, Sunderkoetter C, Henes J, Krusche M, Schmalzing M, Worm M, Schmeiser T, Günther C, Aberer E, Susok L, Riemekasten G, Kreuter A, Zeidler G, Juche A, Hadjiski D, Müller-Ladner U, Gaebelein-Wissing N, Distler JHW, Sárdy M, Krieg T, Hunzelmann N.

J Rheumatol. 2019 Apr 1. pii: jrheum.180582. doi: 10.3899/jrheum.180582. [Epub ahead of print]

PMID:
30936287
16.

Anti-ß1-Adrenoreceptor auto-Antibodies in elderly heart failure patients.

Trippel TD, Mueller DN, Obradovic D, Edelmann F, Tahirovic E, Wilck N, Riemekasten G, Dragun D, Busjahn A, Heidecke H, Junker J, Pieske B, Dungen HD, Dechend R.

Front Biosci (Landmark Ed). 2019 Mar 1;24:1037-1049.

PMID:
30844728
17.

[Progress in Systemic Sclerosis - Early, Targeted and Intensive Therapy is the Key to Success].

Riemekasten G.

Dtsch Med Wochenschr. 2019 Feb;144(3):189-193. doi: 10.1055/a-0652-2488. Epub 2019 Jan 31. Review. German.

PMID:
30703839
18.

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey.

Blagojevic J, Bellando-Randone S, Abignano G, Avouac J, Cometi L, Czirják L, Denton CP, Distler O, Frerix M, Guiducci S, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Allanore Y, Müller-Ladner U, Del Galdo F, Matucci-Cerinic M; EUSTAR co-workers.

Arthritis Res Ther. 2019 Jan 24;21(1):35. doi: 10.1186/s13075-019-1822-1.

19.

Beta-1-Adrenergic Receptor Antibodies in Acute Coronary Syndrome: Is Less Sometimes More?

Ernst D, Widera C, Weiberg D, Derlin T, Ahrenstorf G, Sogkas G, Jablonka A, Schmidt RE, Witte T, Heidecke H, Riemekasten G.

Front Cardiovasc Med. 2018 Nov 22;5:170. doi: 10.3389/fcvm.2018.00170. eCollection 2018.

20.

Evaluation of retinal microvascular perfusion in systemic sclerosis: a case-control study.

Rothe M, Rommel F, Klapa S, Humrich JY, Nieberding R, Lange T, Sochurek JAM, Plöttner P, Grisanti S, Riemekasten G, Ranjbar M.

Ann Rheum Dis. 2019 Jun;78(6):857-858. doi: 10.1136/annrheumdis-2018-214541. Epub 2019 Jan 3. No abstract available.

PMID:
30606740
21.

CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease.

Wang K, Zhao J, Chen Z, Li T, Tan X, Zheng Y, Gu L, Guo L, Sun F, Wang H, Li J, Wang X, Riemekasten G, Ye S.

Rheumatology (Oxford). 2019 Mar 1;58(3):557. doi: 10.1093/rheumatology/key425. No abstract available.

PMID:
30590756
22.

Low-dose interleukin-2 therapy for the treatment of systemic lupus erythematosus.

Humrich JY, Riemekasten G.

Curr Opin Rheumatol. 2019 Mar;31(2):208-212. doi: 10.1097/BOR.0000000000000575.

PMID:
30562181
23.

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis.

Cabral-Marques O, Marques A, Giil LM, De Vito R, Rademacher J, Günther J, Lange T, Humrich JY, Klapa S, Schinke S, Schimke LF, Marschner G, Pitann S, Adler S, Dechend R, Müller DN, Braicu I, Sehouli J, Schulze-Forster K, Trippel T, Scheibenbogen C, Staff A, Mertens PR, Löbel M, Mastroianni J, Plattfaut C, Gieseler F, Dragun D, Engelhardt BE, Fernandez-Cabezudo MJ, Ochs HD, Al-Ramadi BK, Lamprecht P, Mueller A, Heidecke H, Riemekasten G.

Nat Commun. 2018 Dec 6;9(1):5224. doi: 10.1038/s41467-018-07598-9.

24.

CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease.

Wang K, Zhao J, Chen Z, Li T, Tan X, Zheng Y, Gu L, Guo L, Sun F, Wang H, Li J, Wang X, Riemekasten G, Ye S.

Rheumatology (Oxford). 2019 Mar 1;58(3):511-521. doi: 10.1093/rheumatology/key341. Erratum in: Rheumatology (Oxford). 2019 Mar 1;58(3):557.

PMID:
30508148
25.

Loss of balance in normal GPCR-mediated cell trafficking.

Cabral-Marques O, Carvalho-Marques AH, Schimke LF, Heidecke H, Riemekasten G.

Front Biosci (Landmark Ed). 2019 Jan 1;24:18-34. Review.

PMID:
30468645
26.

Recent advances in mouse models for systemic sclerosis.

Yue X, Yu X, Petersen F, Riemekasten G.

Autoimmun Rev. 2018 Dec;17(12):1225-1234. doi: 10.1016/j.autrev.2018.06.013. Epub 2018 Oct 12. Review.

PMID:
30316997
27.

Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.

Carreira PE, Carmona L, Joven BE, Loza E, Andreu JL, Riemekasten G, Vettori S, Balbir-Gurman A, Airò P, Walker UA, Damjanov N, Matucci-Cerinic M, Ananieva LP, Rednic S, Czirják L, Distler O, Farge D, Hesselstrand R, Corrado A, Caramaschi P, Tikly M, Allanore Y; the EUSTAR co-authors.

Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):68-75. Epub 2018 Sep 29.

28.

Risk stratification strategy and assessment of disease progression in patients with pulmonary arterial hypertension: Updated Recommendations from the Cologne Consensus Conference 2018.

Leuchte HH, Ten Freyhaus H, Gall H, Halank M, Hoeper MM, Kaemmerer H, Kähler C, Riemekasten G, Ulrich S, Schwaiblmair M, Ewert R.

Int J Cardiol. 2018 Dec 1;272S:20-29. doi: 10.1016/j.ijcard.2018.08.084. Epub 2018 Sep 13. Review.

PMID:
30266353
29.

[Mimetics of systemic sclerosis].

Jendrek ST, Kahle B, Riemekasten G.

Z Rheumatol. 2019 Feb;78(1):14-23. doi: 10.1007/s00393-018-0538-y. Review. German.

PMID:
30255410
30.

In situ detection of PR3-ANCA+ B cells and alterations in the variable region of immunoglobulin genes support a role of inflamed tissue in the emergence of auto-reactivity in granulomatosis with polyangiitis.

Weppner G, Ohlei O, Hammers CM, Holl-Ulrich K, Voswinkel J, Bischof J, Hasselbacher K, Riemekasten G, Lamprecht P, Ibrahim S, Iking-Konert C, Recke A, Müller A.

J Autoimmun. 2018 Sep;93:89-103. doi: 10.1016/j.jaut.2018.07.004. Epub 2018 Jul 24.

PMID:
30054207
31.

Differences associated with age at onset in early systemic sclerosis patients: a report from the EULAR Scleroderma Trials and Research Group (EUSTAR) database.

Carreira PE, Carmona L, Joven BE, Loza E, Andréu JL, Riemekasten G, Vettori S, Balbir-Gurman A, Airò P, Walker U, Damjanov N, Matucci-Cerinic M, Ananieva LP, Rednic S, Czirják L, Distler O, Farge D, Hesselstrand R, Corrado A, Caramaschi P, Tikly M, Allanore Y.

Scand J Rheumatol. 2019 Jan;48(1):42-51. doi: 10.1080/03009742.2018.1459830. Epub 2018 Jul 24.

PMID:
30039730
32.

Induction of Hypergammaglobulinemia and Autoantibodies by Salmonella Infection in MyD88-Deficient Mice.

Issac JM, Mohamed YA, Bashir GH, Al-Sbiei A, Conca W, Khan TA, Iqbal A, Riemekasten G, Bieber K, Ludwig RJ, Cabral-Marques O, Fernandez-Cabezudo MJ, Al-Ramadi BK.

Front Immunol. 2018 Jun 20;9:1384. doi: 10.3389/fimmu.2018.01384. eCollection 2018.

33.

Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis.

Siegert E, March C, Otten L, Makowka A, Preis E, Buttgereit F, Riemekasten G, Müller-Werdan U, Norman K.

Nutrition. 2018 Nov;55-56:51-55. doi: 10.1016/j.nut.2018.03.046. Epub 2018 Apr 3.

PMID:
29960157
34.

Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study.

Giil LM, Aarsland D, Hellton K, Lund A, Heidecke H, Schulze-Forster K, Riemekasten G, Vik-Mo AO, Kristoffersen EK, Vedeler CA, Nordrehaug JE.

J Alzheimers Dis. 2018;64(3):761-774. doi: 10.3233/JAD-170882.

PMID:
29914018
35.

Circulating CD4+CD8+ double-positive T-cells display features of innate and adaptive immune function in granulomatosis with polyangiitis.

Kerstein A, Müller A, Pitann S, Riemekasten G, Lamprecht P.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):93-98. Epub 2018 May 18.

PMID:
29799396
36.

Autoantibodies against muscarinic acetylcholine receptor M3 in Sjogren's syndrome and corresponding mouse models.

Yu X, Riemekasten G, Petersen F.

Front Biosci (Landmark Ed). 2018 Jun 1;23:2053-2064. Review.

PMID:
29772545
37.

Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.

Lamprecht P, Kerstein A, Klapa S, Schinke S, Karsten CM, Yu X, Ehlers M, Epplen JT, Holl-Ulrich K, Wiech T, Kalies K, Lange T, Laudien M, Laskay T, Gemoll T, Schumacher U, Ullrich S, Busch H, Ibrahim S, Fischer N, Hasselbacher K, Pries R, Petersen F, Weppner G, Manz R, Humrich JY, Nieberding R, Riemekasten G, Müller A.

Front Immunol. 2018 Apr 9;9:680. doi: 10.3389/fimmu.2018.00680. eCollection 2018. Review.

38.

Detection of anti-neutrophil cytoplasmic and antinuclear autoantibodies favouring misdiagnoses in 5 cases of Erdheim-Chester disease.

Özden F, Schinke S, Thorns C, Eckey T, Dalhoff K, Münte TF, Tronnier V, Humrich JY, Riemekasten G, Lamprecht P.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):176. Epub 2018 Apr 10. No abstract available.

PMID:
29652657
39.

Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.

Recke A, Regensburger AK, Weigold F, Müller A, Heidecke H, Marschner G, Hammers CM, Ludwig RJ, Riemekasten G.

Front Immunol. 2018 Mar 22;9:428. doi: 10.3389/fimmu.2018.00428. eCollection 2018.

40.

Diagnosis of deficiency of adenosine deaminase 2 with early onset polyarteritis nodosa in an adult patient with a novel compound heterozygous CECR1 mutation.

Lamprecht P, Humrich JY, Diebold I, Riemekasten G.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):177. Epub 2018 Mar 15. No abstract available.

41.

Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis.

Weigold F, Günther J, Pfeiffenberger M, Cabral-Marques O, Siegert E, Dragun D, Philippe A, Regensburger AK, Recke A, Yu X, Petersen F, Catar R, Biesen R, Hiepe F, Burmester GR, Heidecke H, Riemekasten G.

Arthritis Res Ther. 2018 Mar 22;20(1):52. doi: 10.1186/s13075-018-1545-8.

42.

The impact of malnutrition on quality of life in patients with systemic sclerosis.

Preis E, Franz K, Siegert E, Makowka A, March C, Riemekasten G, Cereda E, Norman K.

Eur J Clin Nutr. 2018 Apr;72(4):504-510. doi: 10.1038/s41430-018-0116-z. Epub 2018 Mar 8.

PMID:
29520082
43.

CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-γ.

Cabral-Marques O, França TT, Al-Sbiei A, Schimke LF, Khan TA, Feriotti C, da Costa TA, Junior OR, Weber CW, Ferreira JF, Tavares FS, Valente C, Di Gesu RSW, Iqbal A, Riemekasten G, Amarante-Mendes GP, Marzagão Barbuto JA, Costa-Carvalho BT, Pereira PVS, Fernandez-Cabezudo MJ, Calich VLG, Notarangelo LD, Torgerson TR, Al-Ramadi BK, Ochs HD, Condino-Neto A.

J Allergy Clin Immunol. 2018 Nov;142(5):1571-1588.e9. doi: 10.1016/j.jaci.2018.02.026. Epub 2018 Mar 5.

44.

Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group.

Adler S, Huscher D, Siegert E, Allanore Y, Czirják L, DelGaldo F, Denton CP, Distler O, Frerix M, Matucci-Cerinic M, Mueller-Ladner U, Tarner IH, Valentini G, Walker UA, Villiger PM, Riemekasten G; EUSTAR co-workers on behalf of the DeSScipher project research group within the EUSTAR network.

Arthritis Res Ther. 2018 Jan 30;20(1):17. doi: 10.1186/s13075-018-1517-z.

45.

Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study.

Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L, Silman AJ, Dinsdale G, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk MC, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jobanputra P, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov NS, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman SM, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2018 Apr;77(4):563-570. doi: 10.1136/annrheumdis-2017-211912. Epub 2018 Jan 6.

46.

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.

Peytrignet S, Denton CP, Lunt M, Hesselstrand R, Mouthon L, Silman A, Pan X, Brown E, Czirják L, Distler JHW, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuta C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, Inanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Herrick AL.

Rheumatology (Oxford). 2018 Feb 1;57(2):370-381. doi: 10.1093/rheumatology/kex410.

47.

Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II Study.

Denton CP, Hachulla É, Riemekasten G, Schwarting A, Frenoux JM, Frey A, Le Brun FO, Herrick AL; Raynaud Study Investigators.

Arthritis Rheumatol. 2017 Dec;69(12):2370-2379. doi: 10.1002/art.40242.

48.

B Cells Are Indispensable for a Novel Mouse Model of Primary Sjögren's Syndrome.

Zheng J, Huang Q, Huang R, Deng F, Yue X, Yin J, Zhao W, Chen Y, Wen L, Zhou J, Huang R, Riemekasten G, Liu Z, Petersen F, Yu X.

Front Immunol. 2017 Oct 24;8:1384. doi: 10.3389/fimmu.2017.01384. eCollection 2017.

49.

Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis.

Arnold MB, Khanna D, Denton CP, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Riemekasten G, Steen V, Müller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE, Pope JE.

Rheumatology (Oxford). 2018 Jan 1;57(1):152-157. doi: 10.1093/rheumatology/kex396.

50.

Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).

Khanna D, Denton CP, Lin CJF, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Pope JE, Riemekasten G, Steen V, Müller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE.

Ann Rheum Dis. 2018 Feb;77(2):212-220. doi: 10.1136/annrheumdis-2017-211682. Epub 2017 Oct 24.

Supplemental Content

Loading ...
Support Center